The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Immune profiling of oral pre-malignant lesions (OPLs): An Erlotinib Prevention of Oral Cancer (EPOC) study biobank analysis.
 
William Nassib William
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Clovis Oncology
Speakers' Bureau - Boehringer Ingelheim
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Merck (Inst); OSI Pharmaceuticals (Inst)
 
Naohiro Uraoka
No Relationships to Disclose
 
S. Andrew Peng
No Relationships to Disclose
 
J. Jack Lee
No Relationships to Disclose
 
Adel K. El-Naggar
No Relationships to Disclose
 
Edwin Roger Parra Cuentas
No Relationships to Disclose
 
Jaime Rodriguez-Canales
No Relationships to Disclose
 
Ann M. Gillenwater
No Relationships to Disclose
 
Heather Y. Lin
No Relationships to Disclose
 
Ignacio Ivan Wistuba
Consulting or Advisory Role - Ariad; AstraZeneca; Asuragen; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Clovis Oncology; GE Healthcare; Genecentric; Genentech/Roche; GlaxoSmithKline; HTG Molecular Diagnostics; Lilly; Lilly; Pfizer; Synta
Speakers' Bureau - Boehringer Ingelheim; Medscape; Pfizer
Research Funding - Bayer; Genentech; HTG Molecular Diagnostics; Jounce Therapeutics; Merck; Myriad Genetics; OncoPlex Diagnostics
 
Jeffrey Myers
No Relationships to Disclose
 
Kathryn A. Gold
Honoraria - Roche/Genentech
Consulting or Advisory Role - ARIAD
Research Funding - ARIAD; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Pharmacyclics; Roche/Genentech
Travel, Accommodations, Expenses - AstraZeneca
 
Patrick Hwu
Stock and Other Ownership Interests - immatics; Lion Biotechnologies
Consulting or Advisory Role - Lion Biotechnologies
Research Funding - Genentech (Inst)
 
John Heymach
Stock and Other Ownership Interests - Bio-Tree; Cardinal Spine
Consulting or Advisory Role - Abbvie; ARIAD; AstraZeneca; AstraZeneca; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Calithera Biosciences; Genentech; Medivation; Novartis; Oncomed; Synta
Research Funding - AstraZeneca (Inst)
 
Vassiliki Papadimitrakopoulou
Consulting or Advisory Role - ARIAD; AstraZeneca; Biothera; Clovis Oncology; Genentech; Genentech; Gensignia Life Sciences; Janssen; Lilly; Merck
Research Funding - ACEA Biosciences (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Clovis Oncology (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
 
Scott Michael Lippman
No Relationships to Disclose